The phenotype of these mice closely resembles T2DM in humans, as male transgenic mice spontaneously develop diabetes mellitus by 8 weeks of age, which is associated with hIAPP deposits in the pancreatic islets, and associated with insulin resistance, leading to β-cell failure and death, as well as impaired insulin secretion and hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.